TORNTPHARM.NS TORRENT PHARMACEUTICALS L | INE685A01028
| Metric | Current | 31.03.2026 | 31.12.2025 |
|---|---|---|---|
| Market Cap | 1.906.784.206.848 | 1.428.307.511.990,63 | 1.302.477.356.950 |
| Enterprise Value | 1.897.863.970.816 | 1.567.390.511.990,63 | 1.302.477.356.950 |
| Trailing P/E | 78,33 | 66,03 | 57,33 |
| Forward P/E | 53,35 | - | - |
| Price to Sales | 13,64 | 10,39 | 10,39 |
| Price to Book | 20,23 | 17,03 | - |
| EV/Revenue | 13,58 | 11,4 | 10,39 |
| EV/EBITDA | 42,21 | 35,1 | 31,99 |